Cargando…

Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release

[Image: see text] Mesoporous silica nanoparticles (MSNPs) have garnered a great deal of attention as potential carriers for therapeutic payloads. However, achieving triggered drug release from MSNPs in vivo has been challenging. Here, we describe the synthesis of stimulus-responsive polymer-coated M...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Neetu, Karambelkar, Amrita, Gu, Luo, Lin, Kevin, Miller, Jordan S., Chen, Christopher S., Sailor, Michael J., Bhatia, Sangeeta N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295203/
https://www.ncbi.nlm.nih.gov/pubmed/21981330
http://dx.doi.org/10.1021/ja206998x
Descripción
Sumario:[Image: see text] Mesoporous silica nanoparticles (MSNPs) have garnered a great deal of attention as potential carriers for therapeutic payloads. However, achieving triggered drug release from MSNPs in vivo has been challenging. Here, we describe the synthesis of stimulus-responsive polymer-coated MSNPs and the loading of therapeutics into both the core and shell domains. We characterize MSNP drug-eluting properties in vitro and demonstrate that the polymer-coated MSNPs release doxorubicin in response to proteases present at a tumor site in vivo, resulting in cellular apoptosis. These results demonstrate the utility of polymer-coated nanoparticles in specifically delivering an antitumor payload.